Here is the AI research roadmap for 2026: how agents that learn, self-correct, and simulate the real world will redefine ...

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

Author Shawn Peters blends clarity and rigor to make data structures and algorithms accessible to all learners. COLORADO, CO, UNITED STATES, January 2, 2026 /EINPresswire.com/ — Vibrant Publishers ...

I played these 25 cards the most and built so many decks around them — or at least dreamed how they might function in the ...

One of the key learning outcomes of university education in general, and liberal arts programmes,  in particular, is that ...

The Arts Council of Princeton (ACP) has announced a three-person exhibition, “Divergent Forms,” featuring the work of artists ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Across five funds, ARK averaged a 39.54% return, underscoring a sharp rebound for Wood’s high-conviction bets in robotics, ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...